Stereospecific high-performance liquid chromatographic analysis of tramadol and its O-demethylated (M1) and N, O-demethylated (M5) metabolites in human plasma by Mehvar, Reza, Elliott, Katherine, Parasrampuria, Ridhi, Eradiri, Okponanabofa

Get full text

FDA Approval Summary: Niraparib for the Maintenance Treatment of Patients with Recurrent Ovarian Cancer in Response to Platinum-Based Chemotherapy by Ison, Gwynn, Howie, Lynn J, Amiri-Kordestani, Laleh, Zhang, Lijun, Tang, Shenghui, Sridhara, Rajeshwari, Pierre, Vadryn, Charlab, Rosane, Ramamoorthy, Anuradha, Song, Pengfei, Li, Fang, Yu, Jingyu, Manheng, Wimolnut, Palmby, Todd R, Ghosh, Soma, Horne, Hisani N, Lee, Eunice Y, Philip, Reena, Dave, Kaushalkumar, Chen, Xiao Hong, Kelly, Sharon L, Janoria, Kumar G, Banerjee, Anamitro, Eradiri, Okponanabofa, Dinin, Jeannette, Goldberg, Kirsten B, Pierce, William F, Ibrahim, Amna, Kluetz, Paul G, Blumenthal, Gideon M, Beaver, Julia A, Pazdur, Richard

Get full text

Single- and multiple-dose bioequivalence of two once-daily tramadol formulations using stereospecific analysis of tramadol and its demethylated (M1 and M5) metabolites by Eradiri, Okponanabofa, Sista, Suryanarayana, Lai, John C. K., Nguyen, Oanh H., Silverstone, Peter H.

Get full text

Pharmacokinetics of a Novel Diltiazem HCl Extended-Release Tablet Formulation for Evening Administration by Sista, Suryanarayana, Lai, John Chi-Keung, Eradiri, Okponanabofa, Albert, Kenneth S.

Get full text

Use of parent drug and metabolite data in bioavailability assessment of a novel diltiazem HCl once-daily product by ERADIRI, O, MIDHA, K. K

Get full text